DK155082A - Fremgangsmaade til fremstilling af et praeparat med cytotoxisk virkning - Google Patents

Fremgangsmaade til fremstilling af et praeparat med cytotoxisk virkning Download PDF

Info

Publication number
DK155082A
DK155082A DK155082A DK155082A DK155082A DK 155082 A DK155082 A DK 155082A DK 155082 A DK155082 A DK 155082A DK 155082 A DK155082 A DK 155082A DK 155082 A DK155082 A DK 155082A
Authority
DK
Denmark
Prior art keywords
preparation
procedure
cytotoxic effect
cytotoxic
effect
Prior art date
Application number
DK155082A
Other languages
Danish (da)
English (en)
Inventor
Johnathan L Kiel
Original Assignee
Johnathan L Kiel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnathan L Kiel filed Critical Johnathan L Kiel
Publication of DK155082A publication Critical patent/DK155082A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • A61K38/385Serum albumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/443Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/18Multi-enzyme systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004Glucose oxidase (1.1.3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01Peroxidases (1.11.1)
    • C12Y111/01007Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK155082A 1981-04-07 1982-04-05 Fremgangsmaade til fremstilling af et praeparat med cytotoxisk virkning DK155082A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/251,694 US4486408A (en) 1981-04-07 1981-04-07 Insoluble crosslinked cytotoxic oxidase-peroxidase system

Publications (1)

Publication Number Publication Date
DK155082A true DK155082A (da) 1982-10-08

Family

ID=22953019

Family Applications (1)

Application Number Title Priority Date Filing Date
DK155082A DK155082A (da) 1981-04-07 1982-04-05 Fremgangsmaade til fremstilling af et praeparat med cytotoxisk virkning

Country Status (13)

Country Link
US (1) US4486408A (en:Method)
EP (1) EP0062434B1 (en:Method)
JP (1) JPS57177694A (en:Method)
AR (1) AR229260A1 (en:Method)
AT (1) ATE15813T1 (en:Method)
AU (1) AU556620B2 (en:Method)
CA (1) CA1187791A (en:Method)
DE (1) DE3266476D1 (en:Method)
DK (1) DK155082A (en:Method)
IL (1) IL65382A (en:Method)
IN (1) IN156471B (en:Method)
NO (1) NO158004C (en:Method)
ZA (1) ZA821924B (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0236610A1 (en) * 1986-03-13 1987-09-16 Laclede Professional Products, Inc. Enzymatic bandages and pads
US4576817A (en) * 1984-06-07 1986-03-18 Laclede Professional Products, Inc. Enzymatic bandages and pads
SE8500341L (sv) * 1985-01-24 1986-07-25 Pharmacia Ab Desinfektionssats samt sett for desinfektion
US4974929A (en) * 1987-09-22 1990-12-04 Baxter International, Inc. Fiber optical probe connector for physiologic measurement devices
AU4402589A (en) * 1988-09-28 1990-04-18 Ideon Corporation Combination enzyme immunotherapeutics
FR2646777B1 (fr) * 1989-05-12 1993-09-03 Bio Serae Lab Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications
US5486360A (en) * 1993-04-22 1996-01-23 St. Joseph Health Centre Method of treating tumour cells using catalase
CA2150029A1 (en) * 1993-09-22 1995-03-30 Spencer H. Lin Immobilization of chemically cross-linked proteins on solid supports
US7192766B2 (en) * 2001-10-23 2007-03-20 Medtronic Minimed, Inc. Sensor containing molded solidified protein
WO2013006762A2 (en) * 2011-07-06 2013-01-10 The Regents Of The University Of California Multiple-enzyme nanocomplexes
KR20250004257A (ko) * 2022-04-13 2025-01-07 엑스옥세미스 인코퍼레이티드 고형 암을 치료하기 위한 조성물 및 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004979A (en) * 1968-03-29 1977-01-25 Agence Nationale De Valorisation De La Recherche (Anvar) Preparation of active proteins cross-linked to inactive proteins
US4178362A (en) * 1969-06-03 1979-12-11 Telec S.A. Enzymatic dentifrices
US3638558A (en) * 1970-03-26 1972-02-01 Burger King Corp Cooking apparatus for comestibles immersed in heated oil
JPS528795B2 (en:Method) * 1971-12-30 1977-03-11
DE2214442C3 (de) * 1972-03-24 1981-09-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Überführung von Glucose in Gluconsäure
DE2307904A1 (de) * 1973-02-17 1974-08-29 Hoechst Ag Verwendung von katalasefreien oder katalsearmen glucoseoxidase-praeparaten als zytostatikum fuer maligne zellen
DK146942C (da) * 1978-04-19 1984-07-30 Novo Industri As Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt
DE2911192A1 (de) * 1979-03-22 1980-10-02 Boehringer Sohn Ingelheim Neuartiges immobilisiertes glucoseoxidase-katalasepraeparat und seine verwendung zur enzymatischen glucoseoxidation

Also Published As

Publication number Publication date
ZA821924B (en) 1983-04-27
EP0062434B1 (en) 1985-09-25
NO158004B (no) 1988-03-21
CA1187791A (en) 1985-05-28
AR229260A1 (es) 1983-07-15
AU556620B2 (en) 1986-11-13
NO821167L (no) 1982-10-08
NO158004C (no) 1988-06-29
DE3266476D1 (en) 1985-10-31
IN156471B (en:Method) 1985-08-10
AU8173982A (en) 1982-10-14
IL65382A0 (en) 1982-05-31
US4486408A (en) 1984-12-04
JPS57177694A (en) 1982-11-01
ATE15813T1 (de) 1985-10-15
IL65382A (en) 1986-04-29
EP0062434A1 (en) 1982-10-13

Similar Documents

Publication Publication Date Title
DK112582A (da) Fremgangsmaade til fremstilling af triazolonderivater
DK66582A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK260682A (da) Fremgangsmaade til fremstilling af partikelformige geler
DK65882A (da) Fremgangsmaade til fremstilling af substituerede phosphonamider
DK346382A (da) Fremgangsmaade til fremstilling af gangliosidderivater
DK435181A (da) Fremgangsmaade til fremstilling af thiazol-derivater
DK84082A (da) Fremgangsmaade til fremstilling af pg12-derivater
DK57480A (da) Fremgangsmaade til fremstilling af insulinderivater
DK491582A (da) Fremgangsmaade til fremstilling af morphinanderivater
DK354382A (da) Fremgangsmaade til fremstilling af aminopyridazinforbindelser
DK352082A (da) Fremgangsmaade til fremstilling af ergopeptinderivater
DK399282A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK153282A (da) Fremgangsmaade til fremstilling af bismethinisoindoliner
DK353781A (da) Fremgangsmaade til fremstilling af insulinderivater
DK239382A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK155082A (da) Fremgangsmaade til fremstilling af et praeparat med cytotoxisk virkning
DK160555C (da) Fremgangsmaade til fremstilling af eburnamoninderivater
DK305982A (da) Fremgangsmaade til fremstilling af amidobenzamider
DK116982A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK108783A (da) Fremgangsmaade til fremstilling af triglycerider
DK70482A (da) Fremgangsmaade til fremstilling af diazolderivater
DK507282A (da) Fremgangsmaade til fremstilling af azinorifamycin forbindelser
DK206582A (da) Fremgangsmaade til fremstilling af et furanderivat
DK375882A (da) Fremgangsmaade til fremstilling af benzisoxazolderivater
DK396482A (da) Fremgangsmaade til fremstilling af cephalosporinderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
PBP Patent lapsed